Technology Transfer & IP company Hebrew University Jerusalem The Hebrew University of Jerusalem
News
185 records page 1-10

15/07/2010

next Using GPS to track crowds and evaluate our health
Using GPS technology, Israeli scientists can track our activities in space and time, spurring a seemingly infinite number of potential applications from medicine to crowd control.
Read More...

25/06/2010

next Potato battery could help meet rural energy needs
Teo Sanchez, energy technology and policy advisor at Practical Action, a charity which promotes technology for development, said: "With half the world's population having no access to modern energy, this research is a valuable contribution to one of the biggest challenges in the world".
Read More...

17/06/2010

next Israeli-developed boiled potato batteries may provide cheap power
An electric battery based on boiled potatoes could provide a cheap source of electricity in the developing world, according to the technology transfer company of the Hebrew University of Jerusalem.
Read More...

16/06/2010

next Yissum spin off Morria Biopharmaceuticals announces Promising Safety, Tolerability and Efficacy Results from MRX-4 Phase II study
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today that it will be presenting the results from its ICH compliant Phase II study of MRX-4 (n=105) in patients suffering from allergic rhinitis at the upcoming 29th EAACI Congress (European Academy of Allergy and Clinical Immunology) in London on June 7th.
Read More...

10/06/2010

next Yissum spin off BriefCam Among Eight Israeli firms named in Red Herring 2010
The eight Israeli companies are attracTV, BriefCam Ltd., MS Tech Ltd., SolarEdge Technologies Ltd., SundaySky, TaKaDu, Trusteer and Waze
Read More...

04/06/2010

next Hebrew University Looks to Commercialize Optimization Algorithm for Drug Discovery Applications
Yissum, the technology-transfer arm of the Hebrew University of Jerusalem, is exploring commercialization plans for a stochastic optimization algorithm that can be used to winnow down large compound libraries to a handful of molecules with the highest probability of possessing specific drug-like characteristics.
Read More...

03/06/2010

next Promising Safety, Tolerability and Efficacy Results from Yissum Spin Off Morria Biopharmaceuticals' MRX-4 Phase II Study in Allergic Rhinitis to be Presented at the upcoming EAACI Congress
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today that it will be presenting the results from its ICH compliant Phase II study of MRX-4 (n=105) in patients suffering from allergic rhinitis at the upcoming 29th EAACI Congress (European Academy of Allergy and Clinical Immunology) in London on June 7th.
Read More...

01/06/2010

next Yissum Spin off Atox Bio: Time to fight septic shock
Atox Bio is an Israeli Biotechnology company that develops therapeutics for diseases mediated by an excessive inflammatory response.
Read More...

25/05/2010

next Yissum Introduces a Breakthrough Computational Method for Superfast Drug Discovery
Yissum introduces Dralgo, a novel computational platform for accelerated discovery of promising drug candidates. The new technology will be presented by its inventor, Professor Amiram Goldblum from the Institute of Drug Research at the Hebrew University of Jerusalem, on Tuesday, June 15 at the Technology Transfer Session II of the ILSI Biomed Israel 2010 conference, to be held at the David Intercontinental Hotel, Tel Aviv, Israel.
Read More...

24/05/2010

next Computer Algorithm Can Recognize Sarcasm
The pursuit of machine intelligence means we have to come up with ways to communicate with our computers in a way both entities can understand. But while computers process verbal commands in a straightforward fashion, humans tend to use more sophisticated speech forms, employing slang or symbols to convey an idea. So an Israeli research team has developed a machine algorithm that can recognize sarcasm.
Read More...

23/05/2010

next YIssum spin off BriefCam Video Synopsis Wins 2010 IFSEC Security Industry Award
BriefCam’s Video Synopsis – the technology that enables users to browse hours of video in minutes – was named “CCTV System Product of the Year”
Read More...

21/04/2010

next Yissum Licenses Cutting Edge Technology for Enhanced Digital Image Processing to Adobe Systems
The technology, invented by Dr. Raanan Fattal from the Hebrew University's School of Computer Science and Engineering, is called Edge Avoiding Wavelets and it enables better and faster detail enhancement and preserves edges when sharpening digital images.
Read More...

14/04/2010

next Avraham Pharmaceuticals Ltd. has raised $9 million from Clal Biotechnology Industries, Yissum Technology Transfer Company of the Hebrew University of Jerusalem, the Pontifax Fund LP, Prof. Marta Weinstock-Rosin of the Hebrew University and other investors
Yissum also said that, together with the Technion Research and Development Foundation (TRDF), the technology transfer arm of the Technion Israel Institute of Technology, it will exclusively license to Avraham the commercial rights of Ladostigil, a novel cholinesterase, brain-selective monoamine oxidase inhibitor and europrotective agent for treatment of Alzheimer's disease and other neurodegenerative diseases. The drug has proven to be safe and well tolerated in Phase I/IIa clinical trials.
Read More...

07/04/2010

next ‘Superdominant’ mutant tomato gene could spark revolution
A single gene discovered by Hebrew University and US researchers Prof. Dani Zamir, Dr. Uri Krieger and Dr. Zach Lippman promises to produce tomatoes – one of Israelis’ favorite vegetables – in dramatically higher yields and with better taste. The discovery was patented by Yissum, HU’s technology transfer arm, which is seeking partners for further development and commercialization.
Read More...

21/03/2010

next Yissum CEO Yaacov Michlin interview for Globes [Hebrew]
"We find various ways to bridge the financial gap over the "Valley of Death": bringing our projects to a valid proof of concept."
Read More...

18/03/2010

next Yissum Licensee Protalix Initiates a Phase I Clinical Trial of Acetylcholinesterase for Biodefense Indications
The PRX-105 program is being conducted in collaboration with Professor Hermona Soreq, from the Hebrew University in Jerusalem, Israel, a world leader in the field of acetylcholinesterase research, and based on patents that were licensed to Protalix Ltd. by Yissum.
Read More...

01/03/2010

next Prof. Daniel Mandler, an Argentinean chemist living in Israel since 1963, spent a month working in Buenos Aires [Spanish]
In an interview to “La Nacion”, one of the most important daily newspapers of Latin America, said Prof. Mandler: “I think that if we can convince our respective Ministers of Science to establish an institutional partnership between Argentina and Israel, both countries could benefit. For Mandler and his host, Dr. Ernesto Calvo, Director of the Institute of Physical Chemistry of Materials, Environment and Energy (Inquimae), a collaboration of this type could help join forces in the increasingly competitive arena of world science. Among his various researchs, Mandler developed a way to deposit thin layers of silicon hydroxide: "He invented a very practical way to coat stents [devices to shore up the wall arteries] explains Dr. Calvo. And we realized that we have a method to see in real time how this deposition occurs. We were not planning to make any experiment this month, but we tested it and now we have results which we could publish in a major international magazine. None of us could have done this work separately."
Read More...

17/02/2010

next Yissum Introduces a Novel System for Tracking and Analyzing Human Spatial Behavior by Monitoring People's Mobility for Tourism, Town Planning and Healthcare Applications
The novel system monitors people's movements and use of open space to provide accurate data for use in healthcare, urban planning, retail yield management, law enforcement and tourism management. The technology was developed by Dr. Noam Shoval and Michal Isaacson, of the Hebrew University’s Department of Geography.
Read More...

03/02/2010

next Yissum, Makhteshim to develop environment-friendly crop protection
Yissum and Makhteshim will work together on two projects. The first collaboration is for the development of a novel method for producing slow and controlled release of herbicides. The second collaboration involves a novel insecticidal preparation combining a proprietary Chitin synthesis inhibitor (CSI) and a pathogenic fungus that kills caterpillars of night-flying moths, which are major pests for agriculture worldwide.
Read More...

19/01/2010

next Yissum Spin-off Chiasma signs strategic agreement with Novartis
Oral drug delivery developer Chiasma has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize its Transient Permeability Enhancer (TPE) technology.
Read More...



1 2 3 4 5 NEXT next
 
 
Advanced
Where Science means Business
All rights reserved to Yissum    |    disclaimer ICS בניית אתרים